BlackRock Institutional Trust Company, N.A. - CELL THERAPEUTICS INC ownership

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of CELL THERAPEUTICS INC
ValueSharesWeighting
Q1 2014$14,264,000
+85.0%
4,195,238
+3.9%
0.00%
+100.0%
Q4 2013$7,710,000
+34.9%
4,036,831
+14.5%
0.00%0.0%
Q3 2013$5,714,000
+59.8%
3,525,002
+3.5%
0.00%0.0%
Q2 2013$3,575,0003,405,0740.00%
Other shareholders
CELL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Rotella Capital Management, Inc. 27,000$28,0000.09%
Del Mar Asset Management, LP 95,967$100,0000.06%
First Heartland Consultants, Inc. 74,624$78,0000.04%
Geduld E E 50,000$53,0000.04%
Alpine Partners USVI, LLC 90,017$94,0000.03%
CTC Alternative Strategies, Ltd. 107,300$112,665,0000.03%
WASHINGTON TRUST Co 259,659$273,0000.02%
KNIGHT CAPITAL GROUP LLC 1,019,384$1,081,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 943,671$991,0000.02%
Jane Street Holding, LLC 618,516$649,0000.01%
View complete list of CELL THERAPEUTICS INC shareholders